
Sign up to save your podcasts
Or
Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.
4.6
1313 ratings
Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.
1,716 Listeners
17 Listeners
32 Listeners
66 Listeners
13 Listeners
69 Listeners
0 Listeners
111 Listeners
43,356 Listeners
12,588 Listeners
279 Listeners
3,325 Listeners
6 Listeners
60 Listeners
3,353 Listeners
169 Listeners
3 Listeners
131 Listeners
12 Listeners